Liver Transplantation: Clinical Trials

14 trials for Liver Transplantation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 4 unknown, 3 terminated, 1 enrolling by invitation. 14 Phase 1, 7 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 114Completed 5, Unknown 4, Terminated 3, Enrolling by invitation 1, Recruiting 1
Phase 27Completed 3, Unknown 2, Enrolling by invitation 1, Recruiting 1

Follow Liver Transplantation: new trials by email Literature Review of Liver Transplantation trials Research Report on Liver Transplantation

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Immune Tolerance Induction After Liver Transplantation
Donor Hematopoietic Stem and Progenitor Cell Infusion - Liver Transplantation, Immune Tolerance
Phase 1 / Phase 2RecruitingUniversity of California, Los Angeles122026-02-202026-03-12
Secretin in Ex-situ Liver Perfusion
Secretin administration during ex-situ liver machine perfusion - Liver Transplantation
Phase 1 / Phase 2Enrolling by invitationErasmus Medical Center202025-04-262026-06-16
Safety and Efficacy of Camrelizumab (Anti-PD-1 Antibody) in Recurrent HCC After Liver Transplantation
Camrelizumab treatment - Hepatocellular Carcinoma, Liver Transplantation
Phase 1UnknownThird Affiliated Hospital, Sun Yat-Sen University202020-09-212022-05-03
Safety and Efficacy of PD-1 Inhibitors in Patients With Liver Transplant
JS001(PD-1 inhibitor) - Hepatocellular Carcinoma, Liver Transplantation
Phase 1UnknownShanghai Zhongshan Hospital202019-05-012019-05-31
Evaluate the Efficacy and Safety of 'Immuncell-LC' in Patients Undergoing Liver Transplantation
Immuncell-LC - Liver Transplantation
Phase 1 / Phase 2CompletedGC Cell Corporation192019-01-242023-06-22
Post Static Cold Storage Normothermic Machine Liver Perfusion
Normothermic Machine Liver Perfusion - Liver Transplantation
Phase 1 / Phase 2UnknownUniversity of Oxford302017-05-012017-06-05
Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation
Anti-Thymocyte Globulin - Rabbit, darTreg Infusion, Everolimus - Liver Transplantation
Phase 1TerminatedNational Institute of Allergy and Infectious Diseases (NIAID)152014-12-172020-09-22
Therapeutic Strategy and the Role of Mesenchymal Stromal Cells for ABO Incompatible Liver Transplantation
Mesenchymal Stem Cells(MSCs) - Liver Transplantation
Phase 1 / Phase 2UnknownThird Affiliated Hospital, Sun Yat-Sen University152014-02-012016-03-11
Extracorporeal Photopheresis in Liver Transplantation. Phase II Clinical Trial in Safety and Efficacy in Patients With Gradual Decrease of Immunosuppression.
Extracorporeal Photopheresis Procedure (FEC) - Liver Transplantation, Immunosuppression
Phase 1 / Phase 2CompletedRed de Terapia Celular102013-04-012017-03-30
Safety Study of Multipotent Progenitor Cells for Immunomodulation Therapy After Liver Transplantation
MultiStem - Liver Transplantation
Phase 1TerminatedProf. Dr. Marc-H. Dahlke, Ph. D.32013-04-012018-08-17
A Multicenter Study Evaluating the Safety and Tolerability of Intravenous rhMBL in Liver Transplant Recipients.
Intravenous Recombinant Human Mannose-Binding Lectin (rhMBL) - Liver Transplantation
Phase 1TerminatedEnzon Pharmaceuticals, Inc.242006-12-012011-08-09
Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients
Immunosuppression Withdrawal - Liver Transplant, Liver Transplantation
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)202006-06-052018-09-20
Adefovir Plus Vaccination in Transplant Patients Without Hepatitis B That Receive a Core Antibody Positive Liver
Adefovir dipivoxil and hepatitis B vaccination - Hepatitis B, Liver Transplantation
Phase 1 / Phase 2CompletedColumbia University162006-03-012021-08-10
Vasosol Organ Perfusion Solution and Medtronic Portable Bypass System
Vasosol Organ Perfusion Solution and Medtronic Portable Bypass System - Liver Transplantation, Organ Preservation
Phase 1CompletedPolyak, Maximilian202004-07-012009-04-09

Narrower conditions

Carcinoma, Hepatocellular (2)  ·  End Stage Liver Disease (1)  ·  Hepatitis B (1)

Broader conditions

Digestive System Diseases (4)  ·  Liver Diseases (4)  ·  Adenocarcinoma (2)  ·  Carcinoma (2)  ·  Digestive System Neoplasms (2)  ·  Liver Neoplasms (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms by Site (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Blood-Borne Infections (1)  ·  Communicable Diseases (1)  ·  DNA Virus Infections (1)  ·  Hepadnaviridae Infections (1)  ·  Hepatic Insufficiency (1)

Interventions

Acetaminophen (1)  ·  Antilymphocyte Serum (1)  ·  Blood Specimen Collection (1)  ·  Diphenhydramine (1)  ·  Everolimus (1)  ·  FEC protocol (1)  ·  Ganciclovir (1)  ·  Leukapheresis (1)  ·  Liver Transplantation (1)  ·  Methylprednisolone Hemisuccinate (1)  ·  Mycophenolic Acid (1)  ·  Phlebotomy (1)  ·  Prednisone (1)  ·  Tacrolimus (1)  ·  Valganciclovir (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (2)  ·  Third Affiliated Hospital, Sun Yat-Sen University (2)  ·  Columbia University (1)  ·  Enzon Pharmaceuticals, Inc. (1)  ·  Erasmus Medical Center (1)  ·  GC Cell Corporation (1)  ·  Polyak, Maximilian (1)  ·  Prof. Dr. Marc-H. Dahlke, Ph. D. (1)  ·  Red de Terapia Celular (1)  ·  Shanghai Zhongshan Hospital (1)  ·  University of California, Los Angeles (1)  ·  University of Oxford (1)

Countries

United States (5)  ·  China (3)  ·  Germany (1)  ·  Netherlands (1)  ·  South Korea (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Alison Freifeld, MD (1)  ·  Cray V. Noah, MD (1)  ·  James V. Guarrera, M.D. (1)  ·  Jeffrey Bluestone, PhD (1)  ·  Jeffrey Veale, MD (1)  ·  Kyung Suk Suh, MD (1)  ·  Peter Friend (1)  ·  Qizhi Tang, PhD (1)  ·  Robert J Porte, MD, PhD (1)  ·  Robert S Brown, Jr, MD, MPH (1)  ·  Sandy Feng, MD (1)  ·  Sandy Feng, MD, PhD (1)  ·  Sang-Mo Kang, MD, FACS (1)  ·  Yang Yang (1)

Results publications

PMID 22253395, PMID 25648649, PMID 27302659

NIH funding

2009 (1), R34AI095135 (1), U01AI110658 (1)